When traditional finance analysts evaluate a trading platform’s valuation, they turn to enterprise value-to-revenue multiples. By that metric, Hyperliquid (HYPE) presents a fascinating case study: the on-chain derivatives exchange trades at a 24x EV/Fees multiple, bracketed by Robinhood Markets at 27.6x and CME Group at 19.6x.

The comparison to traditional finance is not merely academic. Hyperliquid’s platform now executes $6.34 billion in daily trading volume — numbers that increasingly compete with — rather than complement — established players in the fintech ecosystem.

The Buyback Engine: $825M and Climbing

Hyperliquid’s Assistance Fund has retired more than $825 million worth of HYPE tokens as of May 2026. The AF channels 82% of platform trading fees into a buy-and-burn mechanism, generating an annualized run-rate of $517 million and producing a buyback yield of 3.5% against the token’s $14.6 billion market capitalization.

By comparison, traditional stock buyback programs — while massive in aggregate dollar terms — rarely achieve the percentage-of-market-cap yield that on-chain mechanisms can deliver through protocol-level revenue routing.

Expanding Beyond Crypto: HIP3’s Equity Perps

Perhaps most interesting for traditional finance observers is HIP3, Hyperliquid’s protocol for trading tokenized equity perps. Traders can gain exposure to WTI crude oil, the S&P 500 index, NVIDIA, and Tesla — all from a crypto wallet, 24 hours a day, 7 days a week.

Seven months after launch, HIP3 comprises 33.5% of the platform’s total trading volume, suggesting genuine demand for traditional asset exposure through on-chain infrastructure.

What the Fully Diluted Picture Shows

The fully-diluted valuation of $43.7 billion across 1 billion tokens yields a 71.8x multiple — well above both comparable companies. Key context: 455.8 million tokens sit in the foundation reserve. The forward unlock schedule releases 9.92 million tokens monthly.

Core contributor unlocks total approximately 119 million per year, against ~11 million in annual AF retirements — a structural consideration for any holder modeling supply dynamics.

Platform Health Indicators

Key Risks and Catalysts

Regulatory clarity remains the paramount unresolved variable. HIP3’s equity perps could face SEC jurisdiction, while commodity perps may benefit from potential CFTC frameworks. Operator concentration is also notable — a single HIP3 deployer (“xyz”) controls roughly 92% of HIP3 volume.

Key catalysts to watch over the next 12 months include whether a second HIP3 deployer captures meaningful market share, whether HIP4 monthly volumes breach the $5 billion threshold, and the trajectory of AF capture rates relative to the 75% threshold.

Source: Allium Research — Onchain Research single-page tear sheet by Elton Shehdula, Research at Allium. May 8, 2026. Figures sourced from Allium hyperliquid schema.